Dr. Akabas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Morris Park Ave
Dept of Physiology Biophysics
Bronx, NY 10461Phone+1 718-430-3360Fax+1 718-430-8819
Summary
- Dr. Myles Akabas is a physician-scientist in Bronx, NY. He received his MD and PhD from Albert Einstein College of Medicine of Yeshiva University. His laboratory develops drugs targeting membrane transport proteins as novel antimalarial drugs. He is Director of the dual degree MD-PhD Medical Scientist Training Program at the Albert Einstein College of Medicine since 2004. He has more than 100 publications that have been cited over 8000 times.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Nephrology, 1985 - 1986
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1983 - 1985
- Albert Einstein College of MedicineClass of 1983
Certifications & Licensure
- NY State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 393 citationsEmerging molecular mechanisms of general anesthetic actionHugh C. Hemmings, Myles H. Akabas, Peter A. Goldstein, James R. Trudell, Beverley A. Orser
Trends in Pharmacological Sciences. 2005-10-01 - 47 citationsThe national MD-PhD program outcomes study: Relationships between medical specialty, training duration, research effort, and career pathsLawrence F. Brass, Myles H. Akabas
JCI Insight. 2019-10-03 - 348 citationsOpen Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.Wesley C. Van Voorhis, John H. Adams, Roberto Adelfio, Vida Ahyong, Myles H. Akabas
Plos Pathogens. 2016-07-28
Journal Articles
- Yeast-based High-Throughput Screen Identifies Plasmodium falciparum Equilibrative Nucleoside Transporter 1 Inhibitors That Kill Malaria ParasitesFrame IJ, Deniskin R, Rinderspacher A, Katz F, Deng SX, Moir RD, Adjalley SH, Coburn-Flynn O, Fidock DA, Willis IM, Landry DW, Akabas MH., ACS Chem Biol., 1/30/2015
Press Mentions
- Novel Technique for Finding Drugs to Combat Malaria DevelopedFebruary 10th, 2015
Grant Support
- Inhibitors of Purine Import into Plasmodium falciparum Kill Malaria ParasitesNIAID2015–Present
- Structure Of GABA-A Receptor Anion-Selective ChannelNational Institute Of Neurological Disorders And Stroke2004–2011
- Medical Scientist Training ProgramNational Institute Of General Medical Sciences2004–2011
- Propofol Interactions With GABA-A ReceptorsNational Institute Of General Medical Sciences2006–2009
- Malaria Pfcrt Transporter: Structure, Function, SortingNational Institute Of Allergy And Infectious Diseases2005–2006
- Structure Of GABA-A Receptor Anion-Selective ChannelNational Institute Of Neurological Disorders And Stroke2000–2003
- General Anesthetic Interactions With GABA-A ReceptorsNational Institute Of General Medical Sciences2000–2002
- Anesthetic Mechanisms And GABA-A Receptor StructureNational Institute Of General Medical Sciences2000–2001
- CFTR Anion Selective Channel--Structure And FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2000
- CFTR Anion Selective Channel--Structure And FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
- Structure Of GABA-A Receptor Anion-Selective ChannelNational Institute Of Neurological Disorders And Stroke1995–2000
- Structure Of GABA-A Receptor Anion-Selective ChannelNational Institute Of Neurological Disorders And Stroke1994
- Molecular Cloning Of The Human Sweet Taste ReceptorNational Institute On Deafness And Other Communication Disorders1991–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: